Lower Airway Microbiota and Lung Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study was aimed at identifying the lower airway microbiota in patients with lung cancer (LC) using protected brush sampling. We enrolled 37 patients undergoing diagnostic bronchoscopy for suspected LC, 26 with LC and 11 with benign diseases. Protected brush specimens were obtained from the contralateral lung and the side of the tumor; these specimens were analyzed by 16S rRNA-based-next-generation sequencing. The results indicated that the biodiversity was not different between groups, and there were no significant differences between the proportion of microorganisms in the tumor and in the contralateral side of patients with LC. In patients with LC, there was a higher abundance of several microorganisms including Capnocytophaga, Haemophilus, Enterococcus, and Streptococcus; whereas, in individuals without LC, Bacteroides, Lactobacillus, or Methylobacterium were more abundant. Malignancy could be determined with an accuracy of 70% by isolating Enterococcus, Capnocytophaga, or Actinomyces. Microbispora indicated benignity with a sensitivity of 55%, specificity of 88%, and accuracy of 78%. Lower airway microbiota in patients with LC is fairly similar in both the tumor and contralateral sites. Endobronchial microbiota is different in patients with and without LC, and these differences may have a potential clinical value as diagnostic or prognostic biomarkers.
Abstract
This study was aimed at identifying the lower airway microbiota in patients with lung cancer (LC) using protected brush sampling. We enrolled 37 patients undergoing diagnostic bronchoscopy for suspected LC, 26 with LC and 11 with benign diseases. Protected brush specimens were obtained from the contralateral lung and the side of the tumor; these specimens were analyzed by 16S rRNA-based-next-generation sequencing. The results indicated that the biodiversity was not different between groups, and there were no significant differences between the proportion of microorganisms in the tumor and in the contralateral side of patients with LC. In patients with LC, there was a higher abundance of several microorganisms including Capnocytophaga, Haemophilus, Enterococcus, and Streptococcus; whereas, in individuals without LC, Bacteroides, Lactobacillus, or Methylobacterium were more abundant. Malignancy could be determined with an accuracy of 70% by isolating Enterococcus, Capnocytophaga, or Actinomyces. Microbispora indicated benignity with a sensitivity of 55%, specificity of 88%, and accuracy of 78%. Lower airway microbiota in patients with LC is fairly similar in both the tumor and contralateral sites. Endobronchial microbiota is different in patients with and without LC, and these differences may have a potential clinical value as diagnostic or prognostic biomarkers.
참고문헌 (32)
- Lynch SV, "The human intestinal microbiome in health and disease", N. Engl. J. Med, 375, pp.2369~2379 (2016)
- Pevsner-Fischer M, "2016. Role of the microbiome in non-gastrointestinal cancers", World J. Clin. Oncol, 7, pp.200~213 (2016)
- Vogtmann E, "Epidemiologic studies of the human microbiome and cancer", Br. J. Cancer, 114, pp.237~242 (2016)
- Schwabe RF, "The microbiome and cancer", Nat. Rev. Cancer, 13, pp.800~812 (2013)
- Nugent JL, "Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas", J. Proteome Res, 13, pp.1921~1929 (2014)
- Brenner DR, "Previous lung diseases and lung cancer risk: a systematic review and meta-analysis", PLoS One, 6, pp.e17479~ (2011)
- Zhan P, "Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis", Eur. J. Cancer, 47, pp.742~747 (2011)
- Cameron SJS, "A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer", PLoS One, 12, pp.e0177062~ (2017)
- Cheng M, "Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism", Cancer Res, 74, pp.4030~4041 (2014)
- Gui QF, "Well-balanced commensal microbiota contributes to anti-cancer response in al lung cancer mouse model", Genet. Mol. Res, 14, pp.5642~5651 (2015)
- Hosgood HD, "The potential role of lung microbiota in lung cancer attributed to household coal burning exposure", Environ. Mol. Mutagen, 55, pp.643~651 (2014)
- Yan X, "Discovery and validation of potential bacterial biomarkers for lung cancer", Am. J. Cancer Res, 5, pp.3111~3122 (2015)
- Lee SH, "Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions", Lung Cancer, 102, pp.89~95 (2016)
- Yu G, "Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features", Genome Biology, 17, pp.163~ (2016)
- Liu HX, "Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects", Int. J. Cancer, 142, pp.769~778 (2018)
- Berger G, "Lung microbiota: genuine or artefact?", Isr. Med. Assoc. J, 15, pp.731~733 (2013)
- Klindworth A, "Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies", Nucleic Acids Res, 41, pp.e1~ (2013)[DOI]
- Schmieder R, "Quality control and preprocessing of metagenomic datasets", Bioinformatics, 27, pp.863~864 (2011)
- "Ea-tools: Command-line tools for processing biological sequencing data" (2011)[URL]
- Edgar RC, "Search and clustering orders of magnitude faster than BLAST", Bioinformatics, 26, pp.2460~2461 (2010)
- Cole JR, "The Ribosomal Database Project : improved alignments and new tools for rRNA analysis", Nucleic Acids Res, 37(Database issue), pp.D141~D145 (2009)
- Caporaso JG, "QIIME allows analysis of high-throughput community sequencing data", Nat. Methods, 7, pp.335~336 (2010)
- Cole JR, "Ribosomal Database Project : data and tools for highthroughput rRNA analysis", Nucleic Acids Res, 42(Database issue), pp.D633~D642 (2014)
- 김보라, "Deciphering Diversity Indices for a Better Understanding of Microbial Communities", Journal of Microbiology and Biotechnology, 27(12), pp.2089~2093 (2017), 한국미생물·생명공학회
- Gronseth R, "Protected sampling is preferable in bronchoscopic studies of the airway microbiome", ERJ Open Res, 3, pp.0019~2017 (2017)
- Burns MB, "Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment", Genome Med, 7, pp.55~ (2015)
- Hieken TJ, "The microbiome of aseptically collected human breast tissue in benign and malignant disease", Sci. Rep, 6, pp.30751~ (2016)
- Laroumagne S, "Bronchial colonization in patients with lung cancer: a prospective study", Eur. Respir. J, 42, pp.220~229 (2013)
- Mao Q, "Interplay between the lung microbiome and lung cancer", Cancer Lett, 415, pp.40~48 (2018)
- Tsay JJ, "Airway microbiota is associated with up-regulation of the PI3K pathway in lung cancer", Am. J. Respir. Crit. Care Med, 98, pp.1188~1198 (2018)
- Gustafson AM, "Airway PI3K pathway activation is an early and reversible event in lung cancer development", Sci. Transl. Med, 2(26), pp.26ra25~ (2010)
- Yan L, "The ubiquitin-CXCR4 axis plays an important role in acute lung infection-enhanced lung tumor metastasis", Clin. Cancer Res, 19, pp.4706~4716 (2013)